Selecting the Optimal Therapy for Mild Asthma

Overview

Journal Ann Am Thorac Soc

Specialty Pulmonary Medicine

Date 2021 Dec 1

PMID 34851246

Authors

Ryan C Murphy

Garbo Mak

Laura C Feemster

Teal S Hallstrand

Affiliations

Soon will be listed here.

References

Busse W, Bateman E, Caplan A, Kelly H, OByrne P, Rabe K . Combined Analysis of Asthma Safety Trials of Long-Acting β-Agonists. N Engl J Med. 2018; 378(26):2497-2505. DOI: 10.1056/NEJMoa1716868. View

Bateman E, Reddel H, OByrne P, Barnes P, Zhong N, Keen C . As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma. N Engl J Med. 2018; 378(20):1877-1887. DOI: 10.1056/NEJMoa1715275. View

Hancox R, Subbarao P, Kamada D, Watson R, Hargreave F, Inman M . Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002; 165(8):1068-70. DOI: 10.1164/ajrccm.165.8.200111-091bc. View

Haney S, Hancox R . Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005; 99(5):566-71. DOI: 10.1016/j.rmed.2004.10.014. View

OConnor B, Aikman S, Barnes P . Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med. 1992; 327(17):1204-8. DOI: 10.1056/NEJM199210223271704. View

. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007; 120(5 Suppl):S94-138. DOI: 10.1016/j.jaci.2007.09.043. View

Beasley R, Holliday M, Reddel H, Braithwaite I, Ebmeier S, Hancox R . Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. N Engl J Med. 2019; 380(21):2020-2030. DOI: 10.1056/NEJMoa1901963. View

Cardet J, Jiang X, Lu Q, Gerard N, McIntire K, Boushey H . Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. J Allergy Clin Immunol. 2019; 144(2):416-425.e7. PMC: 6950766. DOI: 10.1016/j.jaci.2019.01.049. View

Vathenen A, Knox A, Higgins B, Britton J, Tattersfield A . Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988; 1(8585):554-8. DOI: 10.1016/s0140-6736(88)91352-9. View

10.

Arnold D, Hartert T . What we need to know about long-acting ß₂-agonists: déjà vu all over again?. Am J Respir Crit Care Med. 2010; 182(10):1219-20. DOI: 10.1164/rccm.201006-0941ED. View

11.

Giannini D, Di Franco A, Bacci E, Dente F, Vagaggini B, Taccola M . Tolerance to the protective effect of salmeterol in mild untreated asthmatics. Pulm Pharmacol Ther. 2003; 16(6):355-60. DOI: 10.1016/j.pupt.2003.07.001. View

12.

Yates D, Sussman H, Shaw M, Barnes P, Chung K . Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med. 1995; 152(4 Pt 1):1170-4. DOI: 10.1164/ajrccm.152.4.7551366. View

13.

Bateman E, OByrne P, FitzGerald J, Barnes P, Zheng J, Lamarca R . Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2. Ann Am Thorac Soc. 2021; 18(12):2007-2017. PMC: 8750058. DOI: 10.1513/AnnalsATS.202011-1386OC. View

14.

Hardy J, Baggott C, Fingleton J, Reddel H, Hancox R, Harwood M . Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019; 394(10202):919-928. DOI: 10.1016/S0140-6736(19)31948-8. View

15.

Cheung D, Timmers M, Zwinderman A, Bel E, Dijkman J, Sterk P . Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992; 327(17):1198-203. DOI: 10.1056/NEJM199210223271703. View

16.

Sears M, Taylor D, Print C, Lake D, Li Q, Flannery E . Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990; 336(8728):1391-6. DOI: 10.1016/0140-6736(90)93098-a. View

17.

Cockcroft D, McParland C, Britto S, Swystun V, Rutherford B . Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993; 342(8875):833-7. DOI: 10.1016/0140-6736(93)92695-p. View

18.

OByrne P, FitzGerald J, Bateman E, Barnes P, Zhong N, Keen C . Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N Engl J Med. 2018; 378(20):1865-1876. DOI: 10.1056/NEJMoa1715274. View

19.

Bhagat R, Swystun V, Cockcroft D . Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol. 1996; 97(1 Pt 1):47-52. DOI: 10.1016/s0091-6749(96)70282-8. View

20.

Inman M, OByrne P . The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996; 153(1):65-9. DOI: 10.1164/ajrccm.153.1.8542164. View